Yeast Infection Treatment Global Market Report 2025
상품코드:1825588
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
효모 감염증 치료 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 5.6%로 57억 4,000만 달러로 성장합니다. 예측 기간의 성장은 원격 진료를 위한 원격의료 도입 증가, 표적 치료를 위한 맞춤형 의료 접근법, 효과 향상을 위한 병용 요법의 등장, 자연 요법 및 허브 요법의 중요성 증가, 감염 관리를 위한 미생물 기반 치료에 대한 관심 증가 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 유전체 연구의 발전, 소형 정밀진단기기 개발, 효모 감염 진단 및 치료 분야의 기술 발전, 연구개발 투자 증가, 전략적 파트너십 등을 꼽을 수 있습니다.
향후 5년간 5.6%의 성장률 예측은 이 시장의 이전 예측보다 0.3% 소폭 감소한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 인상은 인도와 캐나다에서 조달한 플루코나졸 제네릭과 질 미생물 검사 키트의 가격을 높이고, 감염의 재발 주기를 악화시키고, 여성 의료 클리닉의 비용을 증가시켜 미국 환자들에게 부담을 줄 가능성이 높습니다. 또한 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
자가면역질환의 유병률 증가는 당분간 효모감염증 치료제 시장 확대를 견인할 것으로 예측됩니다. 자가면역질환은 면역체계가 건강한 세포, 조직, 장기를 잘못 공격하여 신체 기능 저하와 생명을 위협하는 합병증을 유발할 수 있습니다. 효모균 감염 치료는 특정 자가면역 증후군과 관련된 재발성 효모균 감염에 대처함으로써 자가면역 질환의 합병증을 관리하고 예방하는 데 중요한 역할을 합니다. 또한 자가면역질환 환자의 진균 감염을 관리함으로써 면역반응을 조절할 수 있는 가능성도 있습니다. 예를 들어 2023년 3월 현재 미국 국립보건원(National Institutes of Health)은 2021년 전 세계 1형 당뇨병(T1DM) 환자 수는 840만 명으로 추산되며, 그해 50만 명의 신규 환자가 보고되었다고 보고했습니다. 예측에 따르면 2040년까지 T1DM 인구는 1,350만 명에서 1,740만 명에 달할 것으로 예측됩니다. 따라서 자가면역질환의 유병률 증가는 효모 감염 치료 시장의 성장을 가속하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 효모 감염증 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 효모 감염증 치료 시장 : 성장률 분석
세계의 효모 감염증 치료 시장 실적 : 규모와 성장, 2019-2024
세계의 효모 감염증 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 효모 감염증 치료 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 효모 감염증 치료 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
파우더
크림 또는 연고
정제 또는 캡슐
기타 유형
세계의 효모 감염증 치료 시장 : 치료별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
치료
수술
세계의 효모 감염증 치료 시장 : 적응증별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
성기 칸디다증
침습성 칸디다증
구강 인두 칸디다증 또는 식도 칸디다증(Thrush)
기타 적응증
세계의 효모 감염증 치료 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구
국소
IV(정맥내) 또는 IM(근육내)
기타 투여 경로
세계의 효모 감염증 치료 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
소매 약국 또는 드러그스토어
병원 약국
전문점
온라인 판매
기타 용도
세계의 효모 감염증 치료 시장 : 서브 세분화 파우더(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
항진균 파우더
약용 보디 파우더
세계의 효모 감염증 치료 시장 : 서브 세분화 크림 또는 연고(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
항진균 크림
질연고
외용 크림
세계의 효모 감염증 치료 시장 : 서브 세분화 정제 또는 캡슐제(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구 항진균정
프로바이오틱스 캡슐
질정
세계의 효모 감염증 치료 시장 : 서브 세분화 기타 유형(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
좌약
스프레이
겔
제7장 지역별·국가별 분석
세계의 효모 감염증 치료 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 효모 감염증 치료 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
효모 감염증 치료 시장 : 경쟁 구도
효모 감염증 치료 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Thermo Fisher Scientific Inc.
Abbott Laboratories
AstraZeneca PLC
Bayer AG
Astellas Pharma Inc.
Torrent Pharmaceuticals
Catalent Inc.
bioMerieux SA
Cipla
Bruker Corporation
Brundavan Laboratories Private Limited
Glenmark Pharmaceuticals Ltd
Zydus Lifesciences
Prestige Consumer Healthcare Inc.
CordenPharma International
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
효모 감염증 치료 시장 2029 : 새로운 기회를 제공하는 국가
효모 감염증 치료 시장 2029 : 새로운 기회를 제공하는 부문
효모 감염증 치료 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Yeast infection treatment refers to medications utilized to address infections resulting from Candida fungus overgrowth, commonly known as yeast infections or candidiasis. These infections can manifest in various body parts such as the mouth (oral thrush), genitals (vaginal yeast infection), skin, and mucous membranes. The treatments aim to alleviate yeast infection symptoms.
Yeast infection treatment come in different forms such as powders, creams, ointments, tablets, or capsules, and can involve medical treatment or surgery. Indications for these treatments include genital candidiasis, invasive candidiasis, oropharyngeal or esophageal candidiasis (thrush), among others. Administration routes include oral, topical, IV (intravenous), or IM (intramuscular), and the treatments are utilized across various applications such as retail pharmacies, hospital pharmacies, specialty stores, online sales, and more.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The yeast infection treatment market research report is one of a series of new reports from The Business Research Company that provides yeast infection treatment market statistics, including yeast infection treatment industry global market size, regional shares, competitors with a yeast infection treatment market share, detailed yeast infection treatment market segments, market trends and opportunities, and any further data you may need to thrive in the yeast infection treatment industry. This yeast infection treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The yeast infection treatment market size has grown strongly in recent years. It will grow from $4.33 billion in 2024 to $4.62 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increased prevalence of yeast infections, growing awareness about fungal infections, aging population, rise in healthcare expenditure globally, and development and approval of new antifungal medications.
The yeast infection treatment market size is expected to see strong growth in the next few years. It will grow to $5.74 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to increasing adoption of telemedicine for remote consultations, personalized medicine approaches for targeted treatment, emergence of combination therapies for enhanced efficacy, growing emphasis on natural and herbal remedies, and focus on microbiome-based therapies for infection management. Major trends in the forecast period include advancements in genomic research, development of compact and accurate diagnostic equipment, technological advancements in the field of yeast infection diagnosis and treatment, increasing investments in research and development, and strategic partnerships.
The forecast of 5.6% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. patients by driving up the cost of fluconazole generics and vaginal microbiome test kits sourced from India and Canada, exacerbating recurrent infection cycles and increasing women's health clinic expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The anticipated increase in autoimmune disease prevalence is forecasted to drive the expansion of the yeast infection treatment market in the foreseeable future. Autoimmune diseases involve the immune system mistakenly attacking healthy cells, tissues, and organs, leading to weakened bodily functions and potentially life-threatening complications. Yeast infection treatments play a crucial role in managing and preventing autoimmune disease complications by addressing recurrent yeast infections associated with certain autoimmune syndromes. Additionally, they may modulate the immune response by managing fungal infections in patients with autoimmune conditions. For instance, as of March 2023, the National Institutes of Health reported an estimated 8.4 million global cases of type 1 diabetes (T1DM) in 2021, with 500,000 new cases reported that year. Projections indicate the T1DM population to reach between 13.5 and 17.4 million by 2040. Hence, the increasing prevalence of autoimmune diseases is fostering the growth of the yeast infection treatment market.
Key players in the yeast infection treatment market are concentrating on introducing innovative solutions, such as non-azole oral antifungals, to enhance their competitive position. A non-azole oral antifungal is a medication designed to combat fungal infections without belonging to the azole class. For instance, in December 2022, SCYNEXIS, a US-based biotechnology company, received approval from the United States Food and Drug Administration (FDA) for BREXAFEMME (ibrexafungerp tablets), marking its second indication. BREXAFEMME is a pioneering non-azole oral antifungal, the first FDA-endorsed therapy for treating vaginal yeast infections (vulvovaginal candidiasis, VVC) and reducing the recurrence of VVC. With its broad-spectrum activity, BREXAFEMME provides a novel alternative, addressing the limited treatment options for patients with recurrent VVC and reshaping the yeast infection treatment market landscape. The recommended dosage of BREXAFEMME for VVC treatment is 300 mg (two 150 mg tablets) administered one day apart, totaling 600 mg (four 150 mg tablets) daily.
In March 2023, GlaxoSmithKline Plc, a UK-based biopharma company, entered into a partnership with Scynexis to advance the development of Brexafemme (isavuconazonium sulfate) for treating vaginal yeast infections. Through this collaboration, the availability and accessibility of this innovative treatment are expected to be significantly enhanced, providing substantial benefits for patients with challenging infections caused by resistant fungi. Scynexis, a US-based biotechnology company, specializes in creating innovative therapies for hard-to-treat infections, with a primary focus on fungal infections.
Major companies operating in the yeast infection treatment market report are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis International AG, Sanofi SA, Thermo Fisher Scientific Inc., Abbott Laboratories, AstraZeneca PLC, Bayer AG, Astellas Pharma Inc., Torrent Pharmaceuticals, Catalent Inc., bioMerieux SA, Cipla, Bruker Corporation, Brundavan Laboratories Private Limited, Glenmark Pharmaceuticals Ltd, Zydus Lifesciences, Prestige Consumer Healthcare Inc., CordenPharma International, Synmedic Laboratories, Basilea Pharmaceutica AG, Jubilant Pharmova Limited, Curia Global Inc., Synexis LLC, Manus Aktteva Biopharma LLP
North America was the largest region in the yeast infection treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yeast infection treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the yeast infection treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The yeast infection treatment market consists of revenues earned by entities by providing diagnostic testing, personalized treatment plans, telemedicine consultations, educational programs and more. The market value includes the value of related goods sold by the service provider or included within the service offering. The yeast infection treatment market also includes sales of miconazole, terconazole, fluconazole, amphotericin B, itraconazole, and caspofungin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Yeast Infection Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on yeast infection treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for yeast infection treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The yeast infection treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Powders; Creams Or Ointments; Tablets Or Capsules; Other Types
2) By Treatment: Medical Treatment; Surgery
3) By Indication: Genital Candidiasis; Invasive Candidiasis; Oropharyngeal Or Esophageal Candidiasis (Thrush); Other Indications
4) By Route Of Administration: Oral; Topical; IV (Intravenous) Or IM (Intramuscular); Other Routes Of Administration
5) By Application: Retail Pharmacies Or Drug Stores; Hospital Pharmacies; Specialty Stores; Online Sales; Other Applications
Subsegments:
1) By Powders: Antifungal Powders; Medicated Body Powders
2) By Creams Or Ointments: Antifungal Creams; Vaginal Ointments; Topical Creams
3) By Tablets Or Capsules: Oral Antifungal Tablets; Probiotic Capsules; Vaginal Tablets
3. Yeast Infection Treatment Market Trends And Strategies
4. Yeast Infection Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Yeast Infection Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Yeast Infection Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Yeast Infection Treatment Market Growth Rate Analysis
5.4. Global Yeast Infection Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Yeast Infection Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Yeast Infection Treatment Total Addressable Market (TAM)
6. Yeast Infection Treatment Market Segmentation
6.1. Global Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Powders
Creams Or Ointments
Tablets Or Capsules
Other Types
6.2. Global Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medical Treatment
Surgery
6.3. Global Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genital Candidiasis
Invasive Candidiasis
Oropharyngeal Or Esophageal Candidiasis (Thrush)
Other Indications
6.4. Global Yeast Infection Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Topical
IV (Intravenous) Or IM (Intramuscular)
Other Routes Of Administration
6.5. Global Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Retail Pharmacies Or Drug Stores
Hospital Pharmacies
Specialty Stores
Online Sales
Other Applications
6.6. Global Yeast Infection Treatment Market, Sub-Segmentation Of Powders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antifungal Powders
Medicated Body Powders
6.7. Global Yeast Infection Treatment Market, Sub-Segmentation Of Creams Or Ointments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antifungal Creams
Vaginal Ointments
Topical Creams
6.8. Global Yeast Infection Treatment Market, Sub-Segmentation Of Tablets Or Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Antifungal Tablets
Probiotic Capsules
Vaginal Tablets
6.9. Global Yeast Infection Treatment Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Suppositories
Sprays
Gels
7. Yeast Infection Treatment Market Regional And Country Analysis
7.1. Global Yeast Infection Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Yeast Infection Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
